# Anogen Life Sciences, Inc. — Form D

Anogen Life Sciences, Inc. of St. Petersburg, FL, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-05. The offering totals $408K, of which $408K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-02-05
- Form: D
- Accession: 0001800417-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $408K
- Amount sold: $408K
- Investors: 12
- Date of first sale: 2021-01-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-388554

## Issuer

- Name: Anogen Life Sciences, Inc.
- CIK: 0001800417
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 7901 4th Street N, Suite 300, St. Petersburg, FL, 33702
- Phone: 404-934-7258

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| David B Adair | Director | St. Petersburg, FL |
| Steven B Bettis | Director | St. Petersburg, FL |
| Andreas B Reiff | Director | St. Petersburg, FL |
| Seth B Yakatan | Director | St. Petersburg, FL |
| Steven B Bettis | Executive Officer | St. Petersburg, FL |

## More

- [CIK 1800417 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1800417&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001800417-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.